Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Wig-1, a novel regulator of N-Myc mRNA and N-Myc-driven tumor growth.
Cell death & disease·2012
The p53 target Wig-1: a regulator of mRNA stability and stem cell fate?
Cell death and differentiation·2011
The frequency of interleukin-10- and interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted lung.
Transplantation proceedings·2005
Activity of two benzofuran-imidazoles, IM/B/4-62 and IM/B/4-66, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
Giornale italiano di chemioterapia·1992
[Adhesion capacity of Enterococcus faecium (SF 68) and Enterococcus faecalis to various substrates].
Giornale italiano di chemioterapia·1992
[Pharmacologic interactions between quinolones and oral hypoglycemic agents. An experimental study on rabbits].
Giornale italiano di chemioterapia·1992
[Pathologic findings in migrants from developing countries: the experience of the S. Chiara di Palermo ambulatory polyclinic].
Giornale italiano di chemioterapia·1991
An "ON-OFF-ON" Fluorescent Sensor Based on N,S,F-Doped Carbon Dots for Selective Detection of MnO4 - and Dopamine Hydrochloride.
Luminescence : the journal of biological and chemical luminescence·2026
Selective visualisation of aromatic and aliphatic suberin domains using combined Sudan Red-7B staining and UV autofluorescence.
Biotechnic & histochemistry : official publication of the Biological Stain Commission·2026
Current Insights into the Phytochemistry, Traditional, and Biological Importance of Matricaria pubescens (Desf.) Schultz.
Endocrine, metabolic & immune disorders drug targets·2026
Syntheses and structures of two norpsilocin derivatives: N-ethyl-4-hy-droxy-tryptamine (4-HO-NET) and 4-hy-droxy-N-propyl-tryptamine (4-HO-NPT).
Acta crystallographica. Section E, Crystallographic communications·2026
Nor-ursodeoxycholic acid in hepatobiliary diseases: A narrative review.
World journal of gastrointestinal pharmacology and therapeutics·2026